Tectonic Therapeutic, Inc. (TECX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US8789721086
Tectonic Therapeutic, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -84.04 m USD |
| EBIT | -84.16 m USD |
| Net income | -74.15 m USD |
| Diluted EPS – continuing operations | -4.05 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
More stocks
- Qijing Machinery (603677.SS)
- Miwon Commerci (002840.KS)
- OXFORD INDUSTRIES INC (OXM)
- Community Healthcare Trust Inc (CHCT)
- Quality Houses Public Company Limited (QH.BK)
- Zhejiang Extek Technology Co. Ltd. A (301399.SZ)
- Semco Technologies Sas (ALSEM.PA)
- Hebei Gongda Keya Energy Technology Co. Ltd. A (301197.SZ)
- Bohus ASA (BOHUS.OL)
- PLUMAS BANCORP (PLBC)
- Marimekko Oyj (MEKKO.HE)
- Shenmao Technology Inc (3305.TW)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.